Samar Kulkarni

Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial

R Powles, Jayesh Mehta, Samar Kulkarni et al. · The Lancet · 2000 · 355 citations

Medicine, Hematology, Oncology +14

Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants

Samar Kulkarni, R Powles, Jennie Treleaven et al. · Blood · 2000 · 150 citations

Life Sciences, Immunology, Infectious Diseases +17

Identification of Patients Who May Benefit From Prophylactic Immunotherapy After Bone Marrow Transplantation for Acute Myeloid Leukemia on the Basis of Lymphocyte Recovery Early After Transplantation

R Powles, Seema Singhal, Jennifer Treleaven et al. · Blood · 1998 · 124 citations · Full text

Medicine, Hematology, Immunology +16

A comparison of vincristine and doxorubicin infusional chemotherapy with methylprednisolone (VAMP) with the addition of weekly cyclophosphamide (C‐VAMP) as induction treatment followed by autografting in previously untreated myeloma

Noopur Raje, R Powles, Samar Kulkarni et al. · British Journal of Haematology · 1997 · 62 citations

Medicine, Oncology, Pharmacology +11

Long-Term Follow-Up of Relapsed Acute Leukemia Treated with Immunotherapy After Allogeneic Transplantation: the Inseparability of Graft-Versus-Host Disease and Graft-Versus-Leukemia, and the Problem of Extramedullary Relapse

Seema Singhal, R Powles, Samar Kulkarni et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1999 · 45 citations

Life Sciences, Hematology, Immunology +17